SkinHealth Systems Inc. (SKIN) vs Verrica Pharmaceuticals Inc. (VRCA)
A side-by-side comparison of SkinHealth Systems Inc. and Verrica Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
SKIN
SkinHealth Systems Inc.
$0.59HealthcareDelayed quote: Oct 6, 2026, 2:55 PM EDT
VRCA
Verrica Pharmaceuticals Inc.
$4.21HealthcareDelayed quote: Oct 6, 2026, 2:54 PM EDT
Total return — SKIN vs VRCA
growth of $100 · dividends reinvested · last 6ySKIN -94.5% (-38.3%/yr)VRCA -95.5% (-40.4%/yr)SKIN compounded faster over this window
SKIN VRCA
SKIN vs VRCA: by the numbers
- •SKIN is the larger company ($76M vs $72M market cap).
- •Both run net losses; SKIN's is the smaller (-9.79% vs -102.84% net margin).
- •VRCA grew revenue faster over the past five years (20.37% vs 9.24% CAGR).
Metrics side by side
Valuation
| Metric | SKIN | VRCA |
|---|---|---|
| P/S ratio | 0.26 | 2.39 |
| P/B ratio | 1.36 | 16.79 |
| EV / EBITDA | 10.31 | N/A |
| FCF yield | 21.95% | N/A |
Profitability
| Metric | SKIN | VRCA |
|---|---|---|
| Gross margin | 66.34% | 85.89% |
| Operating margin | -1.49% | -33.56% |
| Net margin | -9.79% | -102.84% |
| ROE | -51.09% | -724.01% |
| ROIC | -1.02% | -207.23% |
Growth (annualized)
| Metric | SKIN | VRCA |
|---|---|---|
| Revenue CAGR (5Y) | 9.24% | 20.37% |
| Total return CAGR (5Y) | -53.07% | -48.68% |
Frequently asked
- Which has grown faster, SKIN or VRCA?
- Over the past five years, VRCA grew revenue faster — SKIN at a 9.24% CAGR versus VRCA at 20.37%.
- How have SKIN and VRCA total returns compared?
- Over the past 5 years, SKIN delivered -53.07% and VRCA delivered -48.68% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
SkinHealth Systems ROEVerrica Pharmaceuticals ROESkinHealth Systems operating marginVerrica Pharmaceuticals operating marginSkinHealth Systems revenue growthVerrica Pharmaceuticals revenue growthSkinHealth Systems free cash flowVerrica Pharmaceuticals free cash flow
SkinHealth Systems & Verrica Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.